當(dāng)前位置：廈門慧嘉生物科技有限公司>>細(xì)胞因子>>Prospec >>VEGF E （Orf Virus）/重組內(nèi)皮生長因子-E（Orf 病毒）

VEGF E （Orf Virus）/重組內(nèi)皮生長因子-E（Orf 病毒）

返回列表頁

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品牌

廠商性質(zhì)代理商

所在地廈門市

在線詢價(jià) 收藏產(chǎn)品查看聯(lián)系電話

聯(lián)系方式：陳先生查看聯(lián)系方式

更新時(shí)間：2016-01-27 01:02:03瀏覽次數(shù)：258次

聯(lián)系我時(shí)，請告知來自環(huán)保在線

產(chǎn)品分類 品牌分類

  細(xì)胞因子

Prospec

全部產(chǎn)品列表

暫無信息

廈門慧嘉生物科技有限公司

經(jīng)營模式：代理商

商鋪產(chǎn)品：9325條

所在地區(qū)：福建廈門市

聯(lián)系人：陳先生

詢價(jià) 給他留言

產(chǎn)品簡介

VEGF E (Orf Virus)/重組內(nèi)皮生長因子-E（Orf 病毒）產(chǎn)品編號：CYT-263
產(chǎn)品規(guī)格：2μg/10μg/1mg

詳細(xì)介紹

VEGF E （Orf Virus）/重組內(nèi)皮生長因子-E（Orf 病毒）

產(chǎn)品編號：CYT-263
產(chǎn)品規(guī)格：2μg/10μg/1mg

Description	A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 （Dehio et al., 1999; GenBank accession No. AF106020） was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximay 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus （OV）（Lyttle et al., 1994）. Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins （Dehio et al., 1999; Wise et al., 1999）. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 （KDR） resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 （Flt-1）. Furthermore VEGF-E can also not bind to VEGF receptor-3 （FLT-4）. Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.
Source	Escherichia Coli.
Physical Appearance	Sterile Filtered White lyophilized （freeze-dried） powder.
Formulation	The protein was lyophilized from a concentrated （1mg/ml） solution containing PBS pH-7.4.
Solubility	The lyophilized VEGF-E is soluble in water and most aqueous buffers. The lyophilized Vascular Endothelial Growth Factor-E （Orf Virus） should be reconstituted in PBS or medium containing at least 0.1% human or bovine serum albumin to a concentration not lower than 50μg/ml.
Stability	Lyophilized Vascular Endothelial Growth Factor-E Orf Virus although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution VEGF E -OV should be stored at 4°C between 2-7 days and for future use below -18°C. Please prevent freeze-thaw cycles.
Purity	Greater than 90.0% as determined by（a） Analysis by RP-HPLC. （b） Analysis by SDS-PAGE.
Biological Activity	The ED50 for stimulation of 3H-thymidine incorporation and cell proliferation by human umbilical vein endothelial cells for VEGF-E Orf Virus has been determined to be in the range of 5 - 20 ng/ml, corresponding to a specific activity of 2 x 105 Units/mg.
Usage	Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.